Annual savings from FDA generic drug approvals have reached $445 billion in 2023, with year-to-year variations driven by patent expirations of blockbuster drugs. This breakdown shows how generic competition cuts drug costs across the U.S. healthcare system.
Read More
Pricing Pressure and Shortages: How Manufacturer Financial Strain Is Causing Drug Shortages in 2025
Asthalin Inhaler (Salbutamol) vs. Top Alternatives - 2025 Comparison Guide
Tendering Systems in Europe: How Generic Purchasing Works Across the EU
Cetirizine vs Fexofenadine: Which Antihistamine Has Fewer Side Effects?
Partial AUC: Advanced Bioequivalence Measurements Explained
